Figure 1.
MK-specific PDK1 deficiency results in macrothrombocytopenia and a reduced platelet lifespan. (A) Arithmetic means ± standard error of the mean (SEM; n = 6, unpaired 2-tailed Student t test) of Pdk1 transcript levels in platelets and kidneys from Pdk1fl/fl and Pdk1−/− mice. Representative immunoblot of PDK1 protein levels in MKs from Pdk1fl/fl and Pdk1−/− mice (n = 5). mRNA, messenger RNA. (B) Arithmetic means ± SEM of platelet count and mean platelet volume of Pdk1fl/fl and Pdk1−/− mice aged 8 weeks (n = 13), 12 weeks (n = 22), and 18 weeks (n = 10). (C) Arithmetic means ± SEM (n = 12) of mean forward scatter (FSC) signal of Pdk1fl/fl and Pdk1−/− platelets. (D) Arithmetic means ± SEM (n = 8, unpaired 2-tailed Student t test) of relative spleen weight in Pdk1fl/fl and Pdk1−/− mice. (E) TPO levels of Pdk1fl/fl and Pdk1−/− mice. Arithmetic means ± SEM (n = 6, unpaired 2-tailed Student t test) are shown. TPO receptor/c-Mpl protein level in Pdk1fl/fl and Pdk1−/− MKs. Actin was used as loading control. Arithmetic means ± SEM (n = 5, unpaired 2-tailed Student t test) are shown. (F) Platelet counts of Pdk1fl/fl and Pdk1−/− mice before and 4 days after treatment with TPO (2 µg per animal per day). Arithmetic means ± SEM (n = 8, 2-way analysis of variance [ANOVA] with Bonferroni correction for multiple comparisons) are shown. (G) Endogenous survival of Pdk1fl/fl and Pdk1−/− platelets measured by determination of percent fluorescently labeled platelets in vivo at indicated time points after injection of DyLight 488 α-glycoprotein IX (GPIX) (n = 6, unpaired 2-tailed Student t test). (H) Platelet depletion in Pdk1fl/fl and Pdk1−/− mice was induced by IV injection of rat anti-GPIbα antibody (Emfret Analytics). Peripheral platelet counts were determined over a time course of 7 days by flow cytometry. The rate of platelet count recovery as compared with the respective initial platelet count is depicted (n = 4, unpaired 2-tailed Student t test). *P < .05 and **P < .01 as well as ##P < .01 indicate statistically significant differences.

MK-specific PDK1 deficiency results in macrothrombocytopenia and a reduced platelet lifespan. (A) Arithmetic means ± standard error of the mean (SEM; n = 6, unpaired 2-tailed Student t test) of Pdk1 transcript levels in platelets and kidneys from Pdk1fl/fl and Pdk1−/− mice. Representative immunoblot of PDK1 protein levels in MKs from Pdk1fl/fl and Pdk1−/− mice (n = 5). mRNA, messenger RNA. (B) Arithmetic means ± SEM of platelet count and mean platelet volume of Pdk1fl/fl and Pdk1−/− mice aged 8 weeks (n = 13), 12 weeks (n = 22), and 18 weeks (n = 10). (C) Arithmetic means ± SEM (n = 12) of mean forward scatter (FSC) signal of Pdk1fl/fl and Pdk1−/− platelets. (D) Arithmetic means ± SEM (n = 8, unpaired 2-tailed Student t test) of relative spleen weight in Pdk1fl/fl and Pdk1−/− mice. (E) TPO levels of Pdk1fl/fl and Pdk1−/− mice. Arithmetic means ± SEM (n = 6, unpaired 2-tailed Student t test) are shown. TPO receptor/c-Mpl protein level in Pdk1fl/fl and Pdk1−/− MKs. Actin was used as loading control. Arithmetic means ± SEM (n = 5, unpaired 2-tailed Student t test) are shown. (F) Platelet counts of Pdk1fl/fl and Pdk1−/− mice before and 4 days after treatment with TPO (2 µg per animal per day). Arithmetic means ± SEM (n = 8, 2-way analysis of variance [ANOVA] with Bonferroni correction for multiple comparisons) are shown. (G) Endogenous survival of Pdk1fl/fl and Pdk1−/− platelets measured by determination of percent fluorescently labeled platelets in vivo at indicated time points after injection of DyLight 488 α-glycoprotein IX (GPIX) (n = 6, unpaired 2-tailed Student t test). (H) Platelet depletion in Pdk1fl/fl and Pdk1−/− mice was induced by IV injection of rat anti-GPIbα antibody (Emfret Analytics). Peripheral platelet counts were determined over a time course of 7 days by flow cytometry. The rate of platelet count recovery as compared with the respective initial platelet count is depicted (n = 4, unpaired 2-tailed Student t test). *P < .05 and **P < .01 as well as ##P < .01 indicate statistically significant differences.

Close Modal

or Create an Account

Close Modal
Close Modal